{"id":210869,"date":"2024-10-14T06:37:29","date_gmt":"2024-10-14T02:37:29","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-29T20:00:00","slug":"","status":"publish","type":"post","link":"https:\/\/ucnoqta.az\/?p=210869","title":{"rendered":"D\u00f6\u015f implantlar\u0131 d\u00f6\u015f x\u0259r\u00e7\u0259ngin\u0259 s\u0259b\u0259b olur?"},"content":{"rendered":"<p><strong>2011-ci ild\u0259 ilk d\u0259f\u0259 d&ouml;\u015f implantlar\u0131n\u0131n x\u0259r&ccedil;\u0259ng\u0259 s\u0259b\u0259b oldu\u011fu bildirildi. Art\u0131q bir ne&ccedil;\u0259 il ke&ccedil;di v\u0259 indi bunun h\u0259qiq\u0259t\u0259n bel\u0259 olub olmad\u0131\u011f\u0131n\u0131 &ouml;yr\u0259n\u0259 bil\u0259rik.<\/strong><\/p>\n<p>Ucnoqta.az x\u0259b\u0259r verir ki, &ldquo;HealthLine&rdquo; d&ouml;\u015f implantlar\u0131n\u0131n d&ouml;\u015f x\u0259r&ccedil;\u0259ngin\u0259 s\u0259b\u0259b olub-olmad\u0131\u011f\u0131 il\u0259 ba\u011fl\u0131 ara\u015fd\u0131rma apar\u0131b.<br \/>\nM\u0259lum olub ki, m&uuml;asir t\u0259dqiqatlar d&ouml;\u015f x\u0259r&ccedil;\u0259ngi il\u0259 d&ouml;\u015f implantlar\u0131 aras\u0131nda \u0259laq\u0259 tapmay\u0131b.<\/p>\n<p>Ancaq anaplastik b&ouml;y&uuml;k h&uuml;ceyr\u0259li lenfoma (ALCL) adlanan qeyri-adi bir lenfoman\u0131n inki\u015faf riskini art\u0131ra bil\u0259n m&uuml;\u0259yy\u0259n n&ouml;v implantlar var.<br \/>\nD&ouml;\u015f implantlar\u0131 v\u0259 anaplastik b&ouml;y&uuml;k h&uuml;ceyr\u0259li lenfoma (ALCL)<\/p>\n<p>2011-ci ild\u0259 AB\u015e-da d&ouml;\u015f implantlar\u0131 il\u0259 x\u0259r&ccedil;\u0259ng aras\u0131nda m&uuml;mk&uuml;n \u0259laq\u0259 ilk d\u0259f\u0259 qeyd edildi.<br \/>\nBu, d&ouml;\u015f h&uuml;ceyr\u0259l\u0259rind\u0259 \u0259m\u0259l\u0259 g\u0259l\u0259n d&ouml;\u015f x\u0259r&ccedil;\u0259ngi deyil, anaplastik b&ouml;y&uuml;k h&uuml;ceyr\u0259li lenfoma (ALCL) adlanan immun sisteminin x\u0259r&ccedil;\u0259ngidir.<br \/>\nALCL &ccedil;ox nadir g&ouml;r&uuml;l\u0259n qeyri-Hodgkin lenfoma n&ouml;v&uuml;d&uuml;r. Bu tip lenfoma il\u0259 implantlar aras\u0131ndak\u0131 \u0259laq\u0259d\u0259n dan\u0131\u015fsaq, implant\u0131n yax\u0131nl\u0131\u011f\u0131nda &ccedil;ap\u0131q toxumas\u0131nda v\u0259 mayed\u0259 inki\u015faf edir.<\/p>\n<p>&nbsp;H\u0259r hans\u0131 bir x\u0259r&ccedil;\u0259ng kimi, yay\u0131la bil\u0259r. M&uuml;alic\u0259 olmadan &ouml;l&uuml;ml\u0259 n\u0259tic\u0259l\u0259n\u0259 bil\u0259r. Ancaq unutmay\u0131n ki, risk implant\u0131n istehsal&ccedil;\u0131s\u0131ndan v\u0259 onun toxumal\u0131 olub-olmamas\u0131ndan as\u0131l\u0131 ola bil\u0259r.<br \/>\nAnaplastik B&ouml;y&uuml;k H&uuml;ceyr\u0259li Lenfoman\u0131n (ALCL) simptomlar\u0131<br \/>\nGeni\u015fl\u0259nmi\u015f limfa d&uuml;y&uuml;nl\u0259ri;<br \/>\nH\u0259rar\u0259t;<br \/>\nGec\u0259 t\u0259rl\u0259m\u0259l\u0259ri;<br \/>\nKilo itkisi.<br \/>\nDig\u0259r simptomlar da daxil ola bil\u0259r:<br \/>\nS&uuml;d v\u0259zinin davaml\u0131 \u015fi\u015fm\u0259si;<br \/>\n\u0130mplantda topaqlar v\u0259 ya formala\u015fmalar;<br \/>\nD&ouml;\u015f asimmetriyas\u0131;<br \/>\n\u0130mplant yax\u0131nl\u0131\u011f\u0131nda h\u0259ssasl\u0131q v\u0259 ya a\u011fr\u0131.<\/p>\n<p>Simptomlar \u0259m\u0259liyyatdan d\u0259rhal sonra ba\u015f ver\u0259 bil\u0259r, lakin &ccedil;ox vaxt inki\u015faf etm\u0259k &uuml;&ccedil;&uuml;n ill\u0259r laz\u0131md\u0131r. \u018fg\u0259r bir \u015feyd\u0259n \u0259min deyilsinizs\u0259 v\u0259 ya m&uuml;\u0259yy\u0259n simptomlar\u0131n\u0131z varsa, h\u0259kiminizl\u0259 m\u0259sl\u0259h\u0259tl\u0259\u015fin. Onun n&ouml;vb\u0259ti add\u0131m\u0131 &ccedil;ox g&uuml;man ki, sizin &uuml;&ccedil;&uuml;n ultras\u0259s v\u0259 ya MRT sifari\u015f etm\u0259k olacaq.<br \/>\n\u0130mplant \u0259traf\u0131nda art\u0131q maye varsa, inc\u0259 iyn\u0259 aspirasiyas\u0131 il\u0259 n&uuml;mun\u0259 \u0259ld\u0259 edil\u0259 bil\u0259r. K&uuml;tl\u0259 varsa, toxuma biopsiyas\u0131 laz\u0131md\u0131r. Bu n&uuml;mun\u0259l\u0259r s\u0131naq &uuml;&ccedil;&uuml;n laboratoriyaya g&ouml;nd\u0259ril\u0259c\u0259k.<\/p>\n<p><strong>D&ouml;\u015f implantlar\u0131 v\u0259 dig\u0259r x\u0259r&ccedil;\u0259ng n&ouml;vl\u0259ri<\/strong><br \/>\nD&ouml;\u015f implantlar\u0131n\u0131n d&ouml;\u015f x\u0259r&ccedil;\u0259ngi d\u0259 daxil olmaqla h\u0259r hans\u0131 dig\u0259r x\u0259r&ccedil;\u0259ng n&ouml;vl\u0259rinin inki\u015faf riskini art\u0131rd\u0131\u011f\u0131na dair he&ccedil; bir s&uuml;but yoxdur.<\/p>\n<p><strong>D&ouml;\u015f x\u0259r&ccedil;\u0259nginin t\u0259krarlanmas\u0131<\/strong><br \/>\nT\u0259\u0259ss&uuml;f ki, toxumal\u0131 implantlar\u0131n istifad\u0259si il\u0259 d&ouml;\u015f x\u0259r&ccedil;\u0259nginin t\u0259krarlanma riski aras\u0131nda \u0259laq\u0259 var.<\/p>\n<p><strong>\u0130mplant d\u0259yi\u015fiklikl\u0259ri<\/strong><br \/>\n&Ccedil;ap\u0131q toxumas\u0131 implant\u0131n formas\u0131n\u0131 v\u0259 elastikliyini d\u0259yi\u015fdir\u0259 bil\u0259r ki, o, art\u0131q orijinal g&ouml;r&uuml;n&uuml;\u015f&uuml;n\u0259 malik deyil. \u0130mplant\u0131n infeksiyas\u0131 v\u0259 ya y\u0131rt\u0131lmas\u0131 da onun d\u0259yi\u015fm\u0259sin\u0259 s\u0259b\u0259b ola bil\u0259r. Buna g&ouml;r\u0259 bir &ccedil;ox insan onlar\u0131 &ccedil;\u0131xarmaq v\u0259 ya d\u0259yi\u015fdirm\u0259k &uuml;&ccedil;&uuml;n \u0259lav\u0259 \u0259m\u0259liyyat ke&ccedil;irm\u0259lidir.<br \/>\nD&ouml;\u015f implantlar\u0131 \u0259traf\u0131nda d\u0259yi\u015fiklikl\u0259r normal olsa da, nadir hallarda x\u0259r&ccedil;\u0259ngd\u0259n qaynaqlan\u0131r. Statistik olaraq, toxumal\u0131 implantlar ALCL il\u0259 \u0259laq\u0259l\u0259ndirilir. B\u0259lk\u0259 d\u0259 onlar\u0131n kobud s\u0259thi iltihaba s\u0259b\u0259b olur.<\/p>\n<p><strong>\u0130mplantlar\u0131 n\u0259 vaxt &ccedil;\u0131xarmaq laz\u0131md\u0131r<\/strong><br \/>\nM&uuml;mk&uuml;n ALCL \u0259lam\u0259tl\u0259ri:<br \/>\nMaye y\u0131\u011f\u0131lmas\u0131 s\u0259b\u0259bind\u0259n davaml\u0131 \u015fi\u015fkinlik;<br \/>\nD&ouml;\u015fl\u0259rd\u0259 v\u0259 ya \u0259traf\u0131nda, ehtimal ki, qoltuq alt\u0131nda topaklar v\u0259 ya k&uuml;tl\u0259l\u0259r;<br \/>\nd&ouml;\u015f h\u0259ssasl\u0131\u011f\u0131 v\u0259 ya a\u011fr\u0131;<br \/>\nSin\u0259 i&ccedil;ind\u0259 \u015fi\u015f;<br \/>\nD&ouml;\u015f \u015f\u0259klind\u0259 v\u0259 ya &ouml;l&ccedil;&uuml;s&uuml;nd\u0259 d\u0259yi\u015fiklik.<\/p>\n<p>H\u0259r hans\u0131 bir simptom v\u0259 ya d\u0259yi\u015fiklik olarsa d\u0259rhal h\u0259kiminizl\u0259 \u0259laq\u0259 saxlay\u0131n. ALCL m&uuml;alic\u0259si ad\u0259t\u0259n implant\u0131n v\u0259 \u0259trafdak\u0131 &ccedil;ap\u0131q toxumas\u0131n\u0131n c\u0259rrahi &ccedil;\u0131xar\u0131lmas\u0131n\u0131 \u0259hat\u0259 edir.<br \/>\nPrinsipc\u0259, h\u0259r hans\u0131 bir \u0259lam\u0259t yoxdursa, implantlar\u0131n &ccedil;\u0131xar\u0131lmas\u0131na ehtiyac yoxdur. Ancaq unutmay\u0131n ki, implantlar\u0131n\u0131z n\u0259 q\u0259d\u0259r uzun olarsa, m&uuml;xt\u0259lif f\u0259sadlar\u0131n yaranma ehtimal\u0131 bir o q\u0259d\u0259r &ccedil;ox olar. M&uuml;ayin\u0259l\u0259r &uuml;&ccedil;&uuml;n m&uuml;t\u0259madi olaraq h\u0259kiminiz\u0259 ba\u015f &ccedil;\u0259km\u0259lisiniz. Bununla bel\u0259, ALCL riski azd\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2011-ci ild\u0259 ilk d\u0259f\u0259 d&ouml;\u015f implantlar\u0131n\u0131n x\u0259r&ccedil;\u0259ng\u0259 s\u0259b\u0259b oldu\u011fu bildirildi. Art\u0131q bir ne&ccedil;\u0259 il ke&ccedil;di v\u0259 indi bunun h\u0259qiq\u0259t\u0259n bel\u0259 olub olmad\u0131\u011f\u0131n\u0131 &ouml;yr\u0259n\u0259 bil\u0259rik. Ucnoqta.az x\u0259b\u0259r verir ki, &ldquo;HealthLine&rdquo; d&ouml;\u015f&hellip;<\/p>\n","protected":false},"author":1,"featured_media":251278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[100],"tags":[],"class_list":["post-210869","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diger"],"_links":{"self":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/210869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=210869"}],"version-history":[{"count":0,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/210869\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/media\/251278"}],"wp:attachment":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=210869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=210869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=210869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}